USFDA inspects Glenmark Pharmaceuticals’ formulation manufacturing facility in Goa

21 May 2022 Evaluate

The United States Food & Drug Administration (USFDA) has inspected Glenmark Pharmaceuticals’ formulation manufacturing facility based out of Goa, India between May 12, 2022 and May 20, 2022. USFDA has issued Form 483 with five observations after an inspection at company’s formulation manufacturing facility in Goa.

The company is committed to undertake all necessary steps required to address their observations at the earliest. The Company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.

Glenmark Pharma Share Price

1690.95 -2.35 (-0.14%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.